Matches in Wikidata for { <http://www.wikidata.org/entity/Q74285888> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q74285888 description "clinical trial" @default.
- Q74285888 description "ensayu clínicu" @default.
- Q74285888 description "klinisch onderzoek" @default.
- Q74285888 description "клінічне випробування" @default.
- Q74285888 name "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 name "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 type Item @default.
- Q74285888 label "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 label "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 prefLabel "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 prefLabel "A Study of Neoadjuvant Nivolumab + Abemaciclib or Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer" @default.
- Q74285888 P1132 Q74285888-930822AD-7095-47F7-BCB0-E82FD3BDAFAA @default.
- Q74285888 P1476 Q74285888-40E481C0-2853-47A5-90BD-18EBDF146F45 @default.
- Q74285888 P17 Q74285888-0D312E90-389D-4B05-A4A6-ADC5F955DAC9 @default.
- Q74285888 P17 Q74285888-2D872B47-0639-4978-A376-3597CA764598 @default.
- Q74285888 P17 Q74285888-4CB0EEC4-B502-411F-875A-362C318BC2AA @default.
- Q74285888 P17 Q74285888-59E3D4A7-B47F-44A5-B9BA-68B3EF3B0F3D @default.
- Q74285888 P17 Q74285888-74C27B6C-5464-425E-8E89-A7890EE2A76B @default.
- Q74285888 P17 Q74285888-9D0B204B-669C-4EE3-A60A-B97852A15432 @default.
- Q74285888 P17 Q74285888-C1A141B6-1B28-4798-9144-19A4899C6C1E @default.
- Q74285888 P17 Q74285888-E3325DF1-4841-43C2-958F-73AD5ED9438A @default.
- Q74285888 P17 Q74285888-E8D8D8AC-EAEF-419E-A5FC-3859189CF767 @default.
- Q74285888 P1813 Q74285888-2E9A4203-FE1A-4F52-8835-797B54C04585 @default.
- Q74285888 P2899 Q74285888-1707FE21-133B-4049-AEF6-E821E661B720 @default.
- Q74285888 P3098 Q74285888-AFB8C07B-C341-4956-9036-571461E22EE5 @default.
- Q74285888 P31 Q74285888-7B93701B-3D82-47FE-801E-667D6AD05A1C @default.
- Q74285888 P580 Q74285888-C04CF27C-8F96-4654-AAC6-929269595EF4 @default.
- Q74285888 P582 Q74285888-9732A6A6-4EC4-4124-87D1-F02140F48AB6 @default.
- Q74285888 P6099 Q74285888-D6B3405D-D44D-4EBA-B303-76E1514C4BBF @default.
- Q74285888 P8363 Q74285888-D3D18B22-35A4-4113-8BD3-B6C556483863 @default.
- Q74285888 P859 Q74285888-9373E7F6-5147-446D-9399-98B1A3339639 @default.
- Q74285888 P921 Q74285888-9ACD4FD1-AFFA-4247-BB67-C4F36D0EE0ED @default.
- Q74285888 P1132 "+268" @default.
- Q74285888 P1476 "Randomized, Non-comparative Neoadjuvant Phase II Study in Patients With ER+/HER2- Breast Cancer >= 2 cm With Safety Run-in, Assessing Nivolumab + Abemaciclib or Palbociclib + Anastrozole" @default.
- Q74285888 P17 Q1183 @default.
- Q74285888 P17 Q142 @default.
- Q74285888 P17 Q16 @default.
- Q74285888 P17 Q183 @default.
- Q74285888 P17 Q29 @default.
- Q74285888 P17 Q30 @default.
- Q74285888 P17 Q31 @default.
- Q74285888 P17 Q408 @default.
- Q74285888 P17 Q414 @default.
- Q74285888 P1813 "CheckMate 7A8" @default.
- Q74285888 P2899 "+18" @default.
- Q74285888 P3098 "NCT04075604" @default.
- Q74285888 P31 Q30612 @default.
- Q74285888 P580 "2019-10-09T00:00:00Z" @default.
- Q74285888 P582 "2021-05-31T00:00:00Z" @default.
- Q74285888 P6099 Q42824440 @default.
- Q74285888 P8363 Q78089383 @default.
- Q74285888 P859 Q266423 @default.
- Q74285888 P921 Q7041828 @default.